MicroRNAs in cerebral ischemia

31Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The risk of ischemic stroke increases substantially with age, making it the third leading cause of death and the leading cause of long-term disability in the world. Numerous studies demonstrated that genes, RNAs, and proteins are involved in the occurrence and development of stroke. Current studies found that microRNAs (miRNAs or miRs) are also closely related to the pathological process of stroke. miRNAs are a group of short, noncoding RNA molecules playing important role in posttranscriptional regulation of gene expression and they have emerged as regulators of ischemic preconditioning and ischemic postconditioning. Here we give an overview of the expression and function of miRNAs in the brain, miRNAs as biomarkers during cerebral ischemia, and clinical applications and limitations of miRNAs. Future prospects of miRNAs are also discussed. © 2013 Yang Wang et al.

Cite

CITATION STYLE

APA

Wang, Y., Wang, Y., & Yang, G. Y. (2013). MicroRNAs in cerebral ischemia. Stroke Research and Treatment. https://doi.org/10.1155/2013/276540

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free